24 results
FWP
EVOK
Evoke Pharma Inc
3 Sep 13
Free writing prospectus
12:00am
for Females
METO-IN-002 revealed a gender difference not previously detected in smaller gastroparesis studies
Gender effects have been reported in drug …
1.2
METO-IN-002: Gender Disparity in Treatment Effects of
EVK-001 vs. Placebo
Favors Treatment
Favors Placebo
= Women
= Men
*mGCSI-DD = four
8-K
EVOK
Evoke Pharma Inc
26 Apr 22
Other Events
5:13pm
and 2030, respectively. Evoke has also been granted gender-specific patents in the E.U., Japan, and Mexico with coverage until 2032. Furthermore
8-K
EX-99.1
EVOK
Evoke Pharma Inc
9 Aug 18
Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights
4:05pm
and Recent Highlights
Gimoti™ NDA submitted to FDA on June 1st; awaiting 74-Day FDA filing communication letter
Gender-specific patents granted
8-K
EX-10.1
EVOK
Evoke Pharma Inc
2 Dec 13
Departure of Directors or Certain Officers
12:00am
by the Company pursuant to this Agreement shall be void.
(k)Gender. Where the context so requires, the use of the masculine gender shall include
10-K
hgdx7qzl
25 Mar 14
Annual report
12:00am
424B4
hbk9k
25 Sep 13
Prospectus supplement with pricing info
12:00am
DEF 14A
javnafivzp5lw00qvo0
8 Apr 14
Definitive proxy
12:00am
PRE 14A
tz1jxttm0nb
12 Mar 21
Preliminary proxy
8:30am
10-Q
uqrbhq
13 Nov 13
Quarterly report
12:00am